Why Relypsa Inc (RLYP)’s Stock Surged on Friday?

Shares of Relypsa Inc (NASDAQ:RLYP) skyrocketed by more than 12% today after US Food and Drug Administration rejected the potassium-lowering drug ZS-9 of its rival company AstraZeneca...

Keep Reading →